Shattuck Labs’ stock craters as biotech scraps main product candidate after failed trial

The stock hit a low of $1.37 earlier in the session, matching its record closing low that was set in October 2023.

Shattuck Labs’ stock craters as biotech scraps main product candidate after failed trial
The stock hit a low of $1.37 earlier in the session, matching its record closing low that was set in October 2023.